Source:http://linkedlifedata.com/resource/pubmed/id/21334421
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2011-3-25
|
pubmed:abstractText |
This study was performed to investigate the mechanism of the blood-brain tumor-barrier (BTB) permeability increase, which was induced by NS1619, a selective K(Ca) channel activator. Using a rat brain glioma (C6) model, we exam the expression of ZO-1 and occludin in mRNA and protein level at different time point after intracarotid infusion of NS1619 (30 ?g/kg/min) to tumor sites via RT-PCR and Western blot analysis. The mRNA and protein expression of ZO-1 and occludin had no great change before infusion and began to decrease significantly after 2 h NS1619 infusion, which was significantly attenuated by reactive oxygen species (ROS) scavenger (N-2-mercaptopropionyl glycine, MPG). In addition, MPG also significantly inhibited the increase of BTB permeability and malonaldehyde (MDA) level induced by NS1619. This led to the conclusion that NS1619 could time-dependently increase the BTB permeability by down-regulating the expression of tight junction protein, and this effect could be reversed by ROS.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/NS 1619,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channels...,
http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species,
http://linkedlifedata.com/resource/pubmed/chemical/occludin,
http://linkedlifedata.com/resource/pubmed/chemical/zonula occludens-1 protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1872-7972
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
493
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
140-4
|
pubmed:meshHeading |
pubmed-meshheading:21334421-Animals,
pubmed-meshheading:21334421-Benzimidazoles,
pubmed-meshheading:21334421-Blood-Brain Barrier,
pubmed-meshheading:21334421-Brain Neoplasms,
pubmed-meshheading:21334421-Cell Membrane Permeability,
pubmed-meshheading:21334421-Disease Models, Animal,
pubmed-meshheading:21334421-Down-Regulation,
pubmed-meshheading:21334421-Glioma,
pubmed-meshheading:21334421-Male,
pubmed-meshheading:21334421-Membrane Proteins,
pubmed-meshheading:21334421-Phosphoproteins,
pubmed-meshheading:21334421-Potassium Channels, Calcium-Activated,
pubmed-meshheading:21334421-Rats,
pubmed-meshheading:21334421-Rats, Wistar,
pubmed-meshheading:21334421-Reactive Oxygen Species,
pubmed-meshheading:21334421-Tight Junctions
|
pubmed:year |
2011
|
pubmed:articleTitle |
Calcium-activated potassium channel activator down-regulated the expression of tight junction protein in brain tumor model in rats.
|
pubmed:affiliation |
Department of Physiology, Life Science and Biology Pharmacopedia Institution, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning Province, PR China. yantinggu008@yahoo.com.cn
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|